References
Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB: Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. Am J Trop Med Hyg 1999, 60:533–541.
Lell B, Luckner D, Ndjave M, et al.: Randomised, placebocontrolled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 1998, 351:709–713.
Shanks GD, Gordon DM, Klotz FW, et al.: Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. Clin Infect Dis 1998, 27:494–499.
Sukwa TY, Mulenga M, Chisdaka N, et al.: A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia. Am J Trop Med Hyg 1999, 60:521–525.
van der Berg JD, Duvenage CS, Roskell NS, Scott TR: Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa. Clin ther 1999, 21:741–749.
Shapiro TA, Ranasinha CD, Kumar N, Barditch-Crovo P. Prophylactic activity of atovaquone against Plasmodium falciparum in humans. Am J Trop Med Hyg 1999, 60:831–836.
Rights and permissions
About this article
Cite this article
Pearson, R.D. Atovaquone/proguanil for the treatment and prevention of malaria. Curr Infect Dis Rep 3, 47–49 (2001). https://doi.org/10.1007/s11908-001-0058-8
Issue Date:
DOI: https://doi.org/10.1007/s11908-001-0058-8